PPLPHARMA

Finance

finance is selling its 14.72% stake in Shriram Life Insurance to Sanlam Emerging Markets for ₹600 crore, valuing the insurer at ₹4,000 crore. The sale is part of Piramal's plan to exit non-core investments and redeploy capital. Regulatory approvals are required for the transaction, expected to close by March 31, 2026, with proceeds to strengthen Piramal's balance sheet.